Parexel partners with Clariness to speed up clinical trial recruitment
VOYAGE 1 evaluated subcutaneous tremfya for moderate to severe plaque psoriasis. Credit: Hush Naidoo on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more